-
Vaccines Industry Witnesses Essential Demand in Efforts to Safeguard the Population Against COVID-19
prnewswire
April 10, 2020
ResearchAndMarkets.com identifies Unified Communications as one of the key industries seeing increased demand due to the Coronavirus pandemic.
-
Australia’s UQ Covid-19 vaccine candidate advances to preclinical tests
pharmaceutical-technology
April 10, 2020
The University of Queensland (UQ) in Australia has progressed its Covid-19 vaccine candidate into preclinical testing stage.
-
Indian Immunologicals, Griffith University to develop Covid-19 vaccine
pharmaceutical-technology
April 09, 2020
Vaccine manufacturer Indian Immunologicals and Griffith University in Australia have partnered to develop a potential vaccine candidate against Covid-19.
-
Oxford Biomedica joins consortium for coronavirus vaccine
pharmaceutical-technology
April 09, 2020
UK-based gene and cell therapy group Oxford Biomedica has become part of a consortium focussed on the development, scale-up and production of a Covid-19 coronavirus vaccine candidate.
-
University of Bristol, Imophoron to test Covid-19 vaccine candidates
pharmaceutical-technology
April 09, 2020
The University of Bristol and spin-out firm Imophoron are set to assess Covid-19 vaccine candidates in-vivo in a pre-clinical programme.
-
Oxford Biomedica joins consortium for promising COVID-19 vaccine
pharmatimes
April 08, 2020
As of this morning – Wednesday April 8 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 55,242 with 6,159 deaths
-
Johnson & Johnson announces a lead vaccine candidate for COVID-19
worldpharmanews
April 08, 2020
Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020.
-
Inovio commences Phase I trial of DNA vaccine for Covid-19
pharmaceutical-technology
April 08, 2020
Inovio Pharmaceuticals has received approval from the US Food and Drug Administration (FDA) for the investigational new drug (IND) application of its DNA vaccine candidate INO-4800 against Covid-19.
-
GSK partners with Innovax Biotech on Covid-19 vaccine
pharmaceutical-technology
April 07, 2020
GlaxoSmithKline (GSK) has partnered with Xiamen Innovax Biotech to support the development of a recombinant protein-based vaccine candidate against Covid-19.
-
Covid-19 vaccine candidate yields promising data in mice
pharmaceutical-technology
April 06, 2020
Researchers at the University of Pittsburgh School of Medicine in the US have reported encouraging results from initial tests of a Covid-19 vaccine candidate, PittCoVacc, delivered using a fingertip-sized patch in mice.